HLA-DQA1 and urinary bladder carcinoma: The expression of the 3 genes in urothelial cancer ranges from moderate for NKIRAS2 (NCBI), variable for AKTIP (HPA), and variable for HLA-DQA1 as determined by an immune transcriptome analysis in bladder cancer [67].